Cargando…

ABO Blood Type and Outcomes in a Diverse COVID-19 Infected Population

Introduction: There is conflicting data on the association of blood type with COVID-19 infection. Recent studies have shown an association of blood type in acquisition of COVID-19 infection (Zhao et al., medRxiv 2020), but no association in terms of disease mortality (Latz, Ann Hematol 2020). Prior...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paul, Sonal, Patel, Nisha, Kumarasinghe, Chathula, Nimkar, Neil, Singh, Angelica, Vishnuvardhan, Nivetha, Ashraf, Farah, Mazloom, Anita, Kodama, Rich, Kalsi, Amardeep, Usta, Soeb, Ashfaq, Abeer, Gregos, Peter, Khan, Uqba, Weingarten, Jeremy, Patel, Eshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	904.Outcomes Research-Non-Malignant Conditions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330326/ http://dx.doi.org/10.1182/blood-2020-142943

Ejemplares similares

COVID-19 Prognostic Score Utilizing Hematological and Inflammatory Markers to Determine Outcomes of Hospitalized Patients
por: Kalsi, Amardeep, et al.
Publicado: (2020)

Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation
por: Kodama, Rich, et al.
Publicado: (2020)

Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients
por: Ashraf, Farah, et al.
Publicado: (2020)

Clinical Course and Outcomes of Sickle Cell Disease Patients with COVID-19 at a New York Hospital
por: Mazloom, Anita, et al.
Publicado: (2020)

The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility in COVID-19: A Retrospective Population Study of 3305 Patients
por: Alduaij, Waleed, et al.
Publicado: (2020)

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry
por: Li, Ang, et al.
Publicado: (2020)

Real World Outcomes of Sars-Cov-2 Thrombosis Rates across Three University Health Systems in the Chicago Metropolitan Area
por: Berg, Stephanie, et al.
Publicado: (2020)

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry
por: Gavrilina, Olga A., et al.
Publicado: (2020)

Thrombotic Complications in COVID-19 Patients: Low Incidence of Thrombotic Complications Among Critically Ill COVID-19 Patients in Singapore
por: Lim, Cheryl XQ, et al.
Publicado: (2020)

Patient-Focused Benefits of at-Home Versus in-Clinic Administration of Cancer Therapy: New Considerations for the COVID-19 Era
por: Sandman, Karen E., et al.
Publicado: (2020)

Incidence of Vascular Thromboembolic Events in Outpatients with Mild COVID-19
por: Eswaran, Harish, et al.
Publicado: (2020)

Assessment of Hematologic and Coagulation Parameters As Predictive Value in COVID-19 with Unfavourable Evolution
por: Popov, Viola Maria, et al.
Publicado: (2020)

Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients
por: Ho, Gwendolyn, et al.
Publicado: (2020)

Association of Blood Type on Clinical Outcomes in Black/African Americans Hospitalized for COVID-19 Infection
por: Cheng, Yan, et al.
Publicado: (2020)

Incidence of Thrombosis and Associated Risk Factors in Hospitalized COVID-19 Patients in a New York City Hospital System
por: Theprungsirikul, Poy P., et al.
Publicado: (2020)

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis
por: Rubinstein, Samuel, et al.
Publicado: (2020)

Hematologic Characteristics of Surviving Versus Non-Surviving COVID-19 Patients in Critical Care Units: Inner-City Hospital Experience, Detroit, MI
por: Balanchivadze, Nino, et al.
Publicado: (2020)

Prediction of COVID-19 Mortality in Patients with Cancer
por: Mantha, Simon, et al.
Publicado: (2020)

Implementation and Preliminary Effectiveness of mHealth Apps for Improving Sickle Cell Disease Care during COVID-19: A Mixed-Methods Evaluation
por: Badawy, Sherif M., et al.
Publicado: (2021)

COVID Vaccination Rates in Children and Adults with Sickle Cell Disease in British Columbia, Canada
por: Merkeley, Hayley, et al.
Publicado: (2021)

Venous Thromboembolism Post-COVID-19 Among Individuals with Sickle Cell Disease
por: Singh, Ashima, et al.
Publicado: (2021)

Four-Fold Increased Mortality from Sars-Cov-2 Infection in Patients with Hematologic Versus Non-Hematologic Malignancies Treated at the Largest Tertiary COVID-19 Center in Chicago/Rush University Medical Center (March 1, 2020-December 31,2020)
por: Yun, Nicole K., et al.
Publicado: (2021)

Comparison of Clinical and Thrombotic Outcomes in Sars-Cov-2- Pneumonia Versus Other Viral Pneumonia in an Urban Academic Medical Center
por: Goldberg, Rachel N., et al.
Publicado: (2021)

ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19
por: Velasco, Pablo, et al.
Publicado: (2021)

Immature Platelets and Disease Severity in Patients Hospitalized with Acute COVID-19 Who Are Vaccinated Against COVID-19
por: Lee, Nicholas C.J., et al.
Publicado: (2021)

Use of Monoclonal Antibody Therapy in Hematologic Patients with Mild-to-Moderate COVID-19: A Retrospective Single-Center Experience
por: Amanam, Idoroenyi, et al.
Publicado: (2021)

Comparison of Characteristics and Laboratory Tests of COVID 19-Hematological Patients from France and Brazil: Identification of Prognostic Driven Profiles
por: Alves, Lucas Bassolli de Oliveira, et al.
Publicado: (2021)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

Ethnic Variation in Hospitalized COVID-19 Patients and Correlation with Coagulopathy, Thrombosis, Prognosis and 30 Day Mortality Outcomes in California's Central Valley
por: Huang, Charity A, et al.
Publicado: (2021)

COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry
por: Castonguay, Mathias, et al.
Publicado: (2021)

Bleeding Complications in Patients with Cancer and COVID 19- Analysis from the COVID 19and Cancer Consortium (CCC19) Registry
por: Shah, Surbhi, et al.
Publicado: (2021)

Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia
por: Gavrilina, Olga A., et al.
Publicado: (2021)

Clinical Profile and Outcome of COVID Positive Hematology Patients during the COVID-19 Pandemic - an Analytical Cross Sectional Study from a Tertiary Care Centre in India
por: Kassim, Faisal, et al.
Publicado: (2021)

Middle East Respiratory Syndrome (MERS) Infection in Hematological and Oncological Patients: A Case Series from a Tertiary Care Center in Saudi Arabia
por: Alaskar, Ahmed, et al.
Publicado: (2019)

Pediatric Sickle Cell Disease and the COVID-19 Pandemic: A Year in Review at Children's National Hospital
por: Martin, Olufunke Y., et al.
Publicado: (2021)

HTLV COMO FATOR DE RISCO E GRAVIDADE AO COVID-19 - RELATO DE DOIS CASOS
por: Carvalho, L.G., et al.
Publicado: (2020)

Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
por: Mazloom, Anita, et al.
Publicado: (2020)

Complete Blood Count Parameters Outperform Putative Inflammatory Markers in Predicting COVID-19 Mortality: A Multimodal Machine Learning Model
por: Idogun, Precious, et al.
Publicado: (2021)

Impact of COVID 19 Pandemic on Health Care Utilization for Patients with Sickle Cell Disease - a Specialty Treatment Center Experience
por: Jain, Akshat, et al.
Publicado: (2021)

The Indirect Costs of the SARS-CoV-2 Pandemic: A Case of Severe Malaria in Brooklyn
por: Fleischman, Eitan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dqibs05kkaci1ut82r3u0t3hjd